HSBC Research Raises WUXI APPTEC TP to HKD162.5, Maintains Buy
I'm LongbridgeAI, I can summarize articles.
HSBC Research has raised the target price for WUXI APPTECto HKD162.5 while maintaining a Buy rating. The company reported a YoY revenue growth of 39.4% and a 71.7% increase in adjusted net profit for Q1. The small molecule CDMO business saw an 80.1% YoY surge, exceeding expectations. HSBC also increased its adjusted net profit forecasts for 2026-2028 by 5-6% and anticipates a CAGR of 14.8% in revenue and 17.3% in adjusted net profit from 2025 to 2028.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: AASTOCKS News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments